{"DataElement":{"publicId":"3030135","version":"1","preferredName":"Bone Scan Medical Imaging Assessment Neoplasm Occurrence Frequency","preferredDefinition":"Text term to represent the identification of lesions during a bone scan assessment.","longName":"BONE_SC_LES_FREQ","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2008800","version":"2.31","preferredName":"Bone Scan Medical Imaging Assessment","preferredDefinition":"information relating to the medical imaging assessment (the determination of the value, significance, or extent of) to create images of bones on a computer screen or on film.","longName":"BONE_MEDIMG_ASSESS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2414920","version":"1","preferredName":"Bone Scan Medical Imaging","preferredDefinition":"A technique to create images of bones on a computer screen or on film. A small amount of radioactive material is injected into a blood vessel and travels through the bloodstream; it collects in the bones and is detected by a scanner.:In medicine, any technology which helps in visualization of any biological process, cell, tissue or organ for the screening, diagnosis, surgical procedure or therapy.","longName":"C17646:C16831","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bone Scan","conceptCode":"C17646","definition":"A nuclear imaging method used to evaluate pathological bone metabolism.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Medical Imaging","conceptCode":"C16831","definition":"In medicine, any technology which helps in visualization of any biological process, cell, tissue or organ for the screening, diagnosis, surgical procedure or therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"027804FD-E3ED-104C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-10-06","modifiedBy":"ONEDATA","dateModified":"2005-10-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233077","version":"1","preferredName":"Assessment","preferredDefinition":"The final result of a determination of the value, significance, or extent of.","longName":"C25367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25367","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F90B5E56-BAFE-0F45-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-08","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-08","modifiedBy":"ONEDATA","dateModified":"2005-06-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"99BA9DC8-4458-4E69-E034-080020C9C0E0","latestVersionIndicator":"Yes","beginDate":"2005-10-06","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3030115","version":"1","preferredName":"Neoplasm Occurrence Frequency","preferredDefinition":"a description of the quantity of tumors identified in the bladder at the time of study entry._An abnormal tissue growth resulted from uncontrolled cell proliferation.  Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant ones exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia.  Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias. -- 2004 (NCI)_An instance of something happening, such as an event or incident._The number of occurrences of something within a given time period. (NCI)","longName":"NEO_OCC_FREQ","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Single","valueDescription":"Single","ValueMeaning":{"publicId":"2815161","version":"1","preferredName":"Single","longName":"2815161","preferredDefinition":"Not accompanied by another or others.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Single","conceptCode":"C48440","definition":"Not accompanied by another or others; exclusive of anyone or anything else.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5DCA53B4-110D-E41A-E040-BB89A6434543","latestVersionIndicator":"Yes","beginDate":"2008-12-11","endDate":null,"createdBy":"LEEB","dateCreated":"2008-12-11","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82B04737-E2C7-95C7-E040-BB89AD436B4C","beginDate":"2010-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-26","modifiedBy":"ONEDATA","dateModified":"2010-03-26","deletedIndicator":"No"},{"value":"Multiple","valueDescription":"Multiple","ValueMeaning":{"publicId":"2939872","version":"1","preferredName":"Multiple","longName":"2939872","preferredDefinition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple","conceptCode":"C17648","definition":"Having, relating to, or consisting of more than one individual, element, part, or other component; manifold.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"737BBCA2-6F16-65F6-E040-BB89AD432B2F","latestVersionIndicator":"Yes","beginDate":"2009-09-13","endDate":null,"createdBy":"MOROZOFA","dateCreated":"2009-09-13","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"82B04737-E2DC-95C7-E040-BB89AD436B4C","beginDate":"2010-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-26","modifiedBy":"ONEDATA","dateModified":"2010-03-26","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3030114","version":"1","preferredName":"Neoplasm Occurrence Frequency","preferredDefinition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.:Occurrence; an instance of something happening.:The number of occurrences of something within a given time period. (NCI)","longName":"C3262:C25275:C25515","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Occurrence","conceptCode":"C25275","definition":"An instance of something happening, such as an event or incident.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Temporal Frequency","conceptCode":"C25515","definition":"The number of occurrences of something within a given time period.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82B04737-E2A2-95C7-E040-BB89AD436B4C","latestVersionIndicator":"Yes","beginDate":"2010-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-26","modifiedBy":"ONEDATA","dateModified":"2010-03-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"82B04737-E2B3-95C7-E040-BB89AD436B4C","latestVersionIndicator":"Yes","beginDate":"2010-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-26","modifiedBy":"ONEDATA","dateModified":"2010-03-26","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2813097","version":"1","longName":"Mass General Hospital","context":"NCIP"},{"publicId":"2813098","version":"1","longName":"MGH New CDEs","context":"NCIP"},{"publicId":"3030983","version":"1","longName":"MGH 09 364","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Lesion?","type":"Preferred Question Text","description":"Lesion?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"82B04737-E2E7-95C7-E040-BB89AD436B4C","latestVersionIndicator":"Yes","beginDate":"2010-03-26","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-03-26","modifiedBy":"REEVESD","dateModified":"2015-05-19","changeDescription":"Curated to support MGH Imaging trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}